News | January 08, 2025
Ajooni Biotech to raise Rs. 45 crore through convertible warrants
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
The cornerstone of the quality ecosystem is the implementation of the Quality Control Orders
Nadda chairs Joint Strategy Meeting with Line Ministries for TB Mukt Bharat Abhiyan- 100-Day Intensified Campaign
2.92 acre facility will combine tradition and innovation, offering new opportunities for holistic healing, specialized clinics, and skill development to be constructed at a cost of around Rs. 185 crore
There was no casualty or loss of human life in the incidence
Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009
The company's portfolio includes 21 commercialized products, 19 approved ANDAs, 4 CGT designations, 6 filed ANDAs, and 45 products in its pipeline
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
Subscribe To Our Newsletter & Stay Updated
